Fig. 6From: CD146 T cells in lung cancer: its function, detection, and clinical implications as a biomarker and therapeutic targetDetection of sCD146 using ELISA. The expression of sCD 146 was significantly higher in patients than in controls (P < 0.05). From the ELISA, the concentration of the sCD146 includes 0.33 ± 0.09 ng/ml in healthy patients (Control), 44.69 ± 0.29 ng/ml, 36.05 ± 0.24 ng/ml, 45.18 ± 0.27 ng/ml in adenocarcinoma, squamous and small cell lung cancer, respectivelyBack to article page